| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a4783407e23a20dbe43d383a5d0fcb5 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-58 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 |
| filingDate |
2005-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6891a46f0dac8abccb9967b688ac4ee8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd21ce29c4ef3c891c8b922af2ecf1d2 |
| publicationDate |
2005-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
NO-20052859-L |
| titleOfInvention |
Process for the preparation of resperidone and its intermediates |
| abstract |
Formation of risperidone is promoted using the enriched Z isomeroxime intermediate (s) of formula (3) or (7). HN OH, in F (3) OH 1 N F (7) The oxide (s) can be isomerically enriched by various techniques including the inclusion of the new acetic acid salt thereof, providing, inter alia, resolution of the isomers and / or by heat conversion. |
| priorityDate |
2002-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |